Cytomegalovirus Disease (DBCOND0042800)

Identifiers

Synonyms

Cytomegalovirus disease / Cytomegaloviral disease, unspecified / Cytomegalovirus Infections / Cytomegalovirus infection / Cytomegalovirus infection (disorder) / Cytomegalic inclusion disease / Cytomegaloviral disease / CMV infection / Cytomegaloviral infections

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04129398	MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)	Letermovir	prevention	3	completed
NCT02439970	A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease	Brincidofovir Valganciclovir	prevention	3	terminated
NCT01573039	Cut Off for the Diagnosis of Cytomegalovirus (CMV) Disease in Serum-positive Kidney Transplant Recipients	No drug interventions	Not Available	Not Available	completed
NCT04904614	Letermovir Use in Heart Transplant Recipients	Letermovir	other	4	active_not_recruiting
NCT00828503	Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients	Everolimus Valganciclovir	treatment	2	unknown_status
NCT00907686	TT-CMV Observational Birth Cohort Study	No drug interventions	Not Available	Not Available	completed
NCT02439957	A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus	Brincidofovir Valganciclovir	prevention	3	terminated
NCT01509404	Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection	COVID immunoglobulin from cured patients Human cytomegalovirus immune globulin Valganciclovir	prevention	4	completed
NCT04225923	A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection	No drug interventions	prevention	2	completed